Lab
Texas Molecular Diagnostics Laboratory
Texas Molecular Diagnostics Laboratory was paid $12K by Medicaid between Jan 2022 and Oct 2023, across 37 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 44% of everything it billed.
33Billing provider infoTEXAS MOLECULAR DIAGNOSTICS LABORATORY
IRVING, TX 75038
IRVING, TX 75038
33aNPI1851059588assigned 11/30/2021
33bProvider typeClinical Medical Laboratory
28Total paid$12K
24GClaims2,805
24DCodes billed37
24AFirst – last monthJan 2022 – Oct 2023
Compared with peers
Next to other Clinical Medical Laboratory providers in Texas
Rank by total paid#231 of 436
Median peer was paid$17K
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 528 | $6K | |
| 2023 | 2,277 | $6K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 44% | 206 | 168 | $5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 38% | 176 | 124 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 13% | 176 | 124 | $1K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 3.1% | 155 | 155 | $360.74 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 176 | 124 | $70.38 |
| 87481 | <1% | 155 | 155 | $37.32 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 155 | 155 | $37.32 |
| 87640 | <1% | 155 | 155 | $37.32 | |
| 87653 | <1% | 155 | 155 | $36.52 | |
| 81333 | 0% | 20 | 20 | $0.00 | |
| 81309 | 0% | 27 | 27 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 61 | 61 | $0.00 |
25 more codes
| 86413 | 0% | 61 | $0.00 | |
| 81249 | 0% | 31 | $0.00 | |
| 81185 | 0% | 27 | $0.00 | |
| 81275 | 0% | 20 | $0.00 | |
| 81321 | 0% | 18 | $0.00 | |
| 87634 | 0% | 61 | $0.00 | |
| 87641 | 0% | 70 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 70 | $0.00 |
| 81311 | 0% | 20 | $0.00 | |
| 87631 | 0% | 61 | $0.00 | |
| 81256 | 0% | 27 | $0.00 | |
| 87496 | 0% | 61 | $0.00 | |
| 87581 | 0% | 61 | $0.00 | |
| 81351 | 0% | 20 | $0.00 | |
| 87498 | 0% | 61 | $0.00 | |
| 87541 | 0% | 61 | $0.00 | |
| 87500 | 0% | 70 | $0.00 | |
| 81320 | 0% | 20 | $0.00 | |
| 81189 | 0% | 27 | $0.00 | |
| 87486 | 0% | 61 | $0.00 | |
| 87532 | 0% | 61 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 70 | $0.00 |
| 81302 | 0% | 27 | $0.00 | |
| 87503 | 0% | 61 | $0.00 | |
| 87556 | 0% | 61 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAGARWAL, VIVEK (OWNER)